Bermuda Cancer and Health Centre and Dana Farber/Brigham and Women's Cancer Center Announce Plans to Partner on the Development of a Radiotherapy Program
Hamilton, Bermuda – September 17, 2015 -- Bermuda Cancer and Health Centre and Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) announce today the signing of a Memorandum of Understanding to collaborate on the development of a radiotherapy program.
“This is the next very important phase in developing radiation therapy plans for the local treatment of cancer patients in Bermuda. Bermuda Cancer and Health Centre recognizes how crucial it is to establish collaborative clinical affiliations with overseas cancer centers so that we will safely and effectively provide the highest quality level of cancer care locally,” says Bermuda Cancer and Health Centre, Executive Director, Tara Soares.
Experts from DF/BWCC will advise Bermuda on issues related to the development of the program, including design of a facility, the creation of clinical radiation oncology policies, procedures and safety protocols and the development of a training and education program. Additionally, BWH will work with Bermuda Cancer and Health Centre to explore the opportunity to participate in research opportunities as well as a telemedicine program.
“We are excited to partner with Bermuda Cancer and Health Centre to expand the radiation oncology services available to patients in Bermuda. We share a commitment to providing patient and family-centered care, and through this partnership, most patients who require radiation therapy will no longer need to travel off the island to receive high quality care,” said Daphne Haas-Kogan, MD, chair, Department of Radiation Oncology, Dana-Farber/Brigham and Women’s Cancer Center and professor at Harvard Medical School.
Partners HealthCare International® (PHI), the international arm of Partners HealthCare, and its member hospitals have worked in collaboration with the Bermuda Cancer and Health Centre, the Bermuda Hospitals Board, as well as Bermuda’s insurance and physician providers to elevate local health care services for nearly 15-years. “The impact of an expanded cancer care program will not only address escalating health care costs for the country, it will also make care more efficient and less stressful for Bermudians. The partnership between DF/BWCC and the Bermuda Cancer and Health Centre marks another important milestone in the work we do on the island,” said Dr. Gilbert H. Mudge, CEO for PHI.
Chairman of Bermuda Cancer and Health Centre’s Board of Directors, Glen Gibbons states, “Dana Farber / Brigham and Women’s Cancer Centre is ranked the 4th Best Hospital for Adult Cancer treatment in the USA, according to the US News Best Hospitals Rankings for 2015. We are proud to partner with them to provide our patients in Bermuda access to the latest therapies at a comprehensive radiation treatment facility with a mission of providing cancer treatment to everyone who needs it, regardless of their ability to pay.”
Bermuda Cancer and Health
Bermuda Cancer and Health Centre is an American College of Radiology (ACR) designated Breast Imaging Centre of Excellence and a registered charity number #70. Clinical services include Digital Mammography, Ultrasound, Breast Biopsy and Bone Densitometry. With two digital mammography suites, the Centre performs over 9000 mammograms per year. Bermuda Cancer and Health Centre strongly believe that health screenings, such as mammograms and ultrasound should be available to everyone regardless of insurance coverage or ability to pay. Providing a specialist approach to patient care, Bermuda Cancer and Health Centre has, flexible hours (including after work and Saturday appointments), a convenient location, and lots of free parking. For more information: www.cancer.bm. For more information about Bermuda Cancer and Health Centre visit our website www.chc.bm or call 236-1001.
Dana-Farber/Brigham and Women’s Cancer Care
Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) offers the combined strengths of two world-renowned leaders in cancer treatment and research to provide the most innovative treatment for adults challenged with cancer. It is consistently the top ranked cancer center in New England by US News and World Report. Dana-Farber Cancer Institute and Brigham and Women’s Hospital are founding members of Dana-Farber/Harvard Cancer Center, the nation’s largest research program and an NCI-designated Comprehensive Cancer Center. Our team of clinical specialists and researchers are committed to conquering cancer by developing new ways to prevent, screen for, and treat the disease. Brigham and Women’s Hospital is a founding member of Partners HealthCare and a teaching hospital at Harvard Medical School.